- Investing.com
Nordicus Partners Corporation operates as publicly traded business accelerator and holding company for Nordic life sciences companies in the United States. The company focused on developing medicines supporting oral health. It also provides corporate finance activities, including business and market development, growth strategies, talent acquisition, partnership building, capital raising, and facilitating company acquisitions and sales. The company was formerly known as EKIMAS Corporation and changed its name to Nordicus Partners Corporation in May 2023. Nordicus Partners Corporation was founded in 1993 and is based in Beverly Hills, California.
Metrics to compare | NORD | Sector Sector - Average of metrics from a broad group of related Industrials sector companies | Relationship RelationshipNORDPeersSector | |
---|---|---|---|---|
P/E Ratio | −11.7x | −4.2x | 9.6x | |
PEG Ratio | 1.25 | 0.02 | 0.03 | |
Price/Book | 0.6x | 1.4x | 1.0x | |
Price / LTM Sales | 6,772.1x | 3.0x | 2.8x | |
Upside (Analyst Target) | - | 30.7% | 11.7% | |
Fair Value Upside | Unlock | 7.4% | 1.5% | Unlock |